Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study (1991)
Source: European Journal of Cancer. Conference titles: European Conference on Clinical Oncology and Cancer Nursing. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHEVALLIER, B et al. Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study. European Journal of Cancer. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 out. 2024. , 1991APA
Chevallier, B., Brown, C., Bruning, P. F., Deschenes, L., Hegg, R., Malzyner, A., et al. (1991). Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study. European Journal of Cancer. Faculdade de Medicina, Universidade de São Paulo.NLM
Chevallier B, Brown C, Bruning PF, Deschenes L, Hegg R, Malzyner A, Marschner N, Paterson A, Prichard KI, Serin D, Spielmann M. Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study. European Journal of Cancer. 1991 ;27( 2 supl.): s55.[citado 2024 out. 17 ]Vancouver
Chevallier B, Brown C, Bruning PF, Deschenes L, Hegg R, Malzyner A, Marschner N, Paterson A, Prichard KI, Serin D, Spielmann M. Droroloxifene , a new antiestrogen in advanced breast cancer, double blind dose finding study. European Journal of Cancer. 1991 ;27( 2 supl.): s55.[citado 2024 out. 17 ]